# Heparin Sodium

NDC: 71839-117
Generic name: Heparin Sodium
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20201229

FDA application: ANDA214804

## Active ingredients

- HEPARIN SODIUM: 2000 [USP'U]/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-117"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-117
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=295ea9c6-d08c-40f0-a908-de0fdac44644